Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds Love Thomson Reuters Corporation (USA) (TRI)?

Page 1 of 2

Hedge funds and other investment firms that we track, manage billions of dollars of their wealthy clients’ money, and needless to say, they are painstakingly thorough when analyzing where to invest this money, as their own wealth depends on it. Regardless of the various methods used by elite investors like David Tepper and Dan Loeb, the resources they expend are second-to-none. This is especially valuable when it comes to small-cap stocks, which is where they generate their strongest outperformance, as their resources give them a huge edge when it comes to studying these stocks compared to the average investor, which is why we intently follow their activity in the small-cap space.

Thomson Reuters Corporation (USA) (NYSE:TRI) was in 12 hedge funds’ portfolios at the end of September. TRI shareholders have witnessed a decrease in hedge fund sentiment of late. There were 17 hedge funds in our database with TRI holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity, but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Broadcom Corporation (NASDAQ:BRCM), Travelers Companies Inc (NYSE:TRV), and Brookfield Asset Management Inc. (USA) (NYSE:BAM) to gather more data points.

Follow Thomson Reuters Corp (NYSE:TRI)
Trade (NYSE:TRI) Now!

According to most traders, hedge funds are perceived as slow, outdated financial tools of years past. While there are greater than an 8000 funds with their doors open at the moment, Our experts look at the moguls of this club, around 700 funds. These money managers oversee bulk of the hedge fund industry’s total capital, and by following their top picks, Insider Monkey has figured out a number of investment strategies that have historically surpassed the S&P 500 index. Insider Monkey’s small-cap hedge fund strategy outstripped the S&P 500 index by 12 percentage points per annum for a decade in their back tests.

Keeping this in mind, we’re going to check out the recent action surrounding Thomson Reuters Corporation (USA) (NYSE:TRI).

Hedge fund activity in Thomson Reuters Corporation (USA) (NYSE:TRI)

At Q3’s end, a total of 12 of the hedge funds tracked by Insider Monkey were long this stock, a fall of 29% from one quarter earlier. With the smart money’s capital changing hands, there exists an “upper tier” of key hedge fund managers who were boosting their holdings considerably (or already accumulated large positions).

According to publicly available hedge fund and institutional investor holdings data compiled by Insider Monkey, Tetrem Capital Management, managed by Daniel Bubis, holds the number one position in Thomson Reuters Corporation (USA) (NYSE:TRI), worth an estimated $100.9 million and comprising 3.4% of its 13F portfolio. The second largest stake is held by Peter Rathjens, Bruce Clarke and John Campbell of Arrowstreet Capital, with a $52.3 million position; 0.2% of its 13F portfolio is allocated to the company. Remaining professional money managers that hold long positions consist of Cliff Asness’s AQR Capital Management, Clint Carlson’s Carlson Capital and David Forster and Peter Wilton’s IBIS Capital Partners.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!